Comparison of Early and Delayed Invasive Strategies in Short-medium Term Among Patients with Non-ST Segment Elevation Acute Coronary Syndrome: A Systematic Review and Meta-analysis

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2019 Aug 13

PMID 31404097

Citations 3

Authors

Ming-Bo Zhang

Chen Guo

Min Li

Yong-Hui Lv

Yu-Dong Fan

Zhi-Lu Wang

Affiliations

Soon will be listed here.

Abstract

Background And Objectives: An invasive approach is recommended as the treatment of patients with non-ST elevated acute coronary syndromes (NSTE-ACS). However, it remains unclear that the optimal time of angiography and intervention for patients with NSTE-ACS at present. This study was designed to compare the effect of early and delayed invasive strategies on short-medium term prognosis in patients with those.

Methods: Pubmed, Cochrane Library and Embase were searched up to Dec-30-2018. Randomized clinical trials comparing an early versus a delayed invasive strategy in patients with NSTE-ACS were included. The primary endpoint (all-cause death and recurrent myocardial infarction) and secondary endpoint (major bleeding and recurrent revascularization), as well as composite endpoint were assessed by random or fixed effected meta-analysis with software RevMan 5.3 version after short-medium term follow up.

Result: A total of six randomized clinical trials involving 4,277 early or delayed invasive strategies patients with NSTE-ACS were included in the meta-analysis. Time to coronary angiography varied from 0.5 to 24 h in the early invasive strategy and from 18.6 to 72 h in the delayed invasive strategy. There was a statistical difference in the primary endpoint of all-cause death among patients with NSTE-ACS between early and delayed invasive strategies (4.6% vs 6%; OR:0.76; 95% CI:0.58 to 1.00; P = 0.05; I2 = 0%), but not for recurrent myocardial infarction (6.0% vs 6.3%; OR: 0.94; 95% CI: 0.55 to 1.61; P = 0.82; I2 = 60%). The major bleeding in patients with NSTE-ACS was similar between both invasive strategies (2.7% vs 3.1%; OR:0.88; 95% CI:0.59 to 1.31; P = 0.54; I2 = 0%). However, the composite endpoint in the early invasive strategy patients with NSTE-ACS was significantly lower than that of the delayed invasive strategy (10.9% vs 13.9%; OR:0.76; 95% CI:0.63 to 0.92; P = 0.006; I2 = 0%), and the recurrent revascularization between both strategies was just the opposite (8.7% vs 5.9%; OR:1.5; 95%CI:1.15 to 1.97; P = 0.003; I2 = 0%).

Conclusion: The systematic review and meta-analysis demonstrated that the early invasive strategy had a beneficial trend on all-cause death and significantly reduced the composite endpoint in patients with NSTE-ACS, but increased the rate of revascularization. These data could provide a solution for patients with those.

Citing Articles

Acute Coronary Syndrome: Treatment Strategies and Outcomes in Patients Admitted to a Tertiary Care Hospital in Palestine.

Abukhalil A, Hamad S, Swaileh Z, Ghanem A, Abumadi S, Madia R Patient Prefer Adherence. 2024; 18:1173-1181.

PMID: 38882643 PMC: 11180461. DOI: 10.2147/PPA.S467924.

Focused Chest Pain Assessment for Early Detection of Acute Coronary Syndrome: Development of a Cardiovascular Digital Health Intervention.

Lukitasari M, Apriliyawan S, Manistamara H, Sella Y, Rohman M, Jonnagaddala J Glob Heart. 2023; 17(1):18.

PMID: 37091222 PMC: 10120604. DOI: 10.5334/gh.1194.

ANMCO POSITION PAPER: Timing of coronary angiography in non-ST-segment elevation acute coronary syndromes.

Murrone A, Scotto di Uccio F, Amodeo V, Aspromonte N, Caldarola P, Casella G Eur Heart J Suppl. 2021; 23(Suppl C):C196-C203.

PMID: 34456646 PMC: 8388606. DOI: 10.1093/eurheartj/suab068.

References

Ronner E, Boersma E, Laarman G, Somsen G, Harrington R, Deckers J . Early angioplasty in acute coronary syndromes without persistent ST-segment elevation improves outcome but increases the need for six-month repeat revascularization: an analysis of the PURSUIT Trial. Platelet glycoprotein IIB/IIIA in Unstable.... J Am Coll Cardiol. 2002; 39(12):1924-9. DOI: 10.1016/s0735-1097(02)01897-1. View

Granger C, Goldberg R, Dabbous O, Pieper K, Eagle K, Cannon C . Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med. 2003; 163(19):2345-53. DOI: 10.1001/archinte.163.19.2345. View

Eagle K, Lim M, Dabbous O, Pieper K, Goldberg R, Van de Werf F . A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA. 2004; 291(22):2727-33. DOI: 10.1001/jama.291.22.2727. View

Stone G, Bertrand M, Colombo A, Dangas G, Farkouh M, Feit F . Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale. Am Heart J. 2004; 148(5):764-75. DOI: 10.1016/j.ahj.2004.04.036. View

Terkelsen C, Lassen J, Norgaard B, Gerdes J, Jensen T, Gotzsche L . Mortality rates in patients with ST-elevation vs. non-ST-elevation acute myocardial infarction: observations from an unselected cohort. Eur Heart J. 2004; 26(1):18-26. DOI: 10.1093/eurheartj/ehi002. View

Fuster V, Badimon L, Badimon J, Chesebro J . The pathogenesis of coronary artery disease and the acute coronary syndromes (2). N Engl J Med. 1992; 326(5):310-8. DOI: 10.1056/NEJM199201303260506. View

Riezebos R, Ronner E, Ter Bals E, Slagboom T, Smits P, Ten Berg J . Immediate versus deferred coronary angioplasty in non-ST-segment elevation acute coronary syndromes. Heart. 2008; 95(10):807-12. DOI: 10.1136/hrt.2008.154815. View

Mehta S, Granger C, Boden W, Steg P, Bassand J, Faxon D . Early versus delayed invasive intervention in acute coronary syndromes. N Engl J Med. 2009; 360(21):2165-75. DOI: 10.1056/NEJMoa0807986. View

Testa L, Latini R, Agostoni P, Banning A, Bedogni F . Prognostic significance of small troponin I rise after a successful elective percutaneous coronary intervention of a native artery. Am J Cardiol. 2009; 103(11):1622-3. DOI: 10.1016/j.amjcard.2009.03.008. View

10.

Fox K, Clayton T, Damman P, Pocock S, de Winter R, Tijssen J . Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data. J Am Coll Cardiol. 2010; 55(22):2435-45. DOI: 10.1016/j.jacc.2010.03.007. View

11.

Katritsis D, Siontis G, Kastrati A, Vant Hof A, Neumann F, Siontis K . Optimal timing of coronary angiography and potential intervention in non-ST-elevation acute coronary syndromes. Eur Heart J. 2010; 32(1):32-40. DOI: 10.1093/eurheartj/ehq276. View

12.

Sciahbasi A, Madonna M, De Vita M, Agati L, Scioli R, Summaria F . Comparison of immediate vs early invasive strategy in patients with first acute non-ST-elevation myocardial infarction. Clin Cardiol. 2010; 33(10):650-655. PMC: 6653721. DOI: 10.1002/clc.20785. View

13.

McManus D, Gore J, Yarzebski J, Spencer F, Lessard D, Goldberg R . Recent trends in the incidence, treatment, and outcomes of patients with STEMI and NSTEMI. Am J Med. 2010; 124(1):40-7. PMC: 3011975. DOI: 10.1016/j.amjmed.2010.07.023. View

14.

Higgins J, Altman D, Gotzsche P, Juni P, Moher D, Oxman A . The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011; 343:d5928. PMC: 3196245. DOI: 10.1136/bmj.d5928. View

15.

Thiele H, Rach J, Klein N, Pfeiffer D, Hartmann A, Hambrecht R . Optimal timing of invasive angiography in stable non-ST-elevation myocardial infarction: the Leipzig Immediate versus early and late PercutaneouS coronary Intervention triAl in NSTEMI (LIPSIA-NSTEMI Trial). Eur Heart J. 2011; 33(16):2035-43. DOI: 10.1093/eurheartj/ehr418. View

16.

Rajpurohit N, Garg N, Garg R, Choudhary A, Fresen J, Boren S . Early versus delayed percutaneous coronary intervention for patients with non-ST segment elevation acute coronary syndrome: a meta-analysis of randomized controlled clinical trials. Catheter Cardiovasc Interv. 2012; 81(2):223-31. DOI: 10.1002/ccd.24439. View

17.

Badings E, The S, Dambrink J, Wijngaarden J, Tjeerdsma G, Rasoul S . Early or late intervention in high-risk non-ST-elevation acute coronary syndromes: results of the ELISA-3 trial. EuroIntervention. 2013; 9(1):54-61. DOI: 10.4244/EIJV9I1A9. View

18.

Tekin K, Cagliyan C, Tanboga I, Balli M, Uysal O, Ozkan B . Influence of the Timing of Percutaneous Coronary Intervention on Clinical Outcomes in Non-ST-Elevation Myocardial Infarction. Korean Circ J. 2013; 43(11):725-30. PMC: 3866311. DOI: 10.4070/kcj.2013.43.11.725. View

19.

Mahmoud K, Hillege H, Lennon R, Gersh B, Holmes Jr D . Timing of intervention and outcome in non-ST-elevation acute coronary syndromes: there is risk on both sides of the curve. Int J Cardiol. 2014; 177(1):23-4. DOI: 10.1016/j.ijcard.2014.09.057. View

20.

Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M . Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015; 350:g7647. DOI: 10.1136/bmj.g7647. View